These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12762568)

  • 1. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity.
    Pistelli R; Lange P; Miller DL
    Eur Respir J Suppl; 2003 May; 40():10s-14s. PubMed ID: 12762568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic mucus hypersecretion in COPD and death from pulmonary infection.
    Prescott E; Lange P; Vestbo J
    Eur Respir J; 1995 Aug; 8(8):1333-8. PubMed ID: 7489800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.
    Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
    Am J Respir Crit Care Med; 2016 Mar; 193(6):662-72. PubMed ID: 26695373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of air pollution in a cohort of patients with chronic obstructive pulmonary disease.
    Faustini A; Stafoggia M; Cappai G; Forastiere F
    Epidemiology; 2012 Nov; 23(6):861-79. PubMed ID: 23018970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
    Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
    Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.
    Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
    Thorax; 1990 Aug; 45(8):579-85. PubMed ID: 2402719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study].
    de Lucas-Ramos P; Izquierdo-Alonso JL; Rodríguez-González Moro JM; Bellón-Cano JM; Ancochea-Bermúdez J; Calle-Rubio M; Calvo-Corbella E; Molina-París J; Pérez-Rodríguez E; Pons S
    Arch Bronconeumol; 2008 May; 44(5):233-8. PubMed ID: 18448013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urban air pollution and chronic obstructive pulmonary disease: a review.
    Sunyer J
    Eur Respir J; 2001 May; 17(5):1024-33. PubMed ID: 11488305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological studies in mucus hypersecretion.
    Vestbo J
    Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations.
    Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ
    Respiration; 2015; 90(3):199-205. PubMed ID: 26278777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential misclassification of causes of death from COPD.
    Jensen HH; Godtfredsen NS; Lange P; Vestbo J
    Eur Respir J; 2006 Oct; 28(4):781-5. PubMed ID: 16807258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
    Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
    Tesfaigzi Y; Meek P; Lareau S
    Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease and risk of infection.
    Lange P
    Pneumonol Alergol Pol; 2009; 77(3):284-8. PubMed ID: 19591100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
    Dijkstra AE; de Jong K; Boezen HM; Kromhout H; Vermeulen R; Groen HJ; Postma DS; Vonk JM
    Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.